Metropolitan Digital

Men's Weekly


.

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues, reducing treatment side effects

  • Written by Aslan Mansurov, Postdoctoral Researcher in Molecular Engineering, University of Chicago Pritzker School of Molecular Engineering
'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues, reducing treatment side effectsDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors.Victor Segura Ibarra and Rita Serda/National Cancer Institute via Flickr, CC BY-NC

Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumor cells, causing a plethora of side effects. Immunotherapies...

Read more: 'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues,...

More Articles ...

  1. Modern-day struggle at James Madison's plantation Montpelier to include the descendants' voices of the enslaved
  2. More student or faculty diversity on campus leads to lower racial gaps in graduation rates
  3. How the role and visibility of chaplains changed over the past century
  4. Firearm stocks spike after mass shootings as investors dismiss the chance of tightening gun laws
  5. Most people support abortion staying legal, but that may not matter in making law
  6. The lasting consequences of school shootings on the students who survive them
  7. 50 years of UN environmental diplomacy: What's worked and the trends ahead
  8. The Asian Canadian gay activist whose theories on sexuality were decades ahead of their time
  9. The Wall of Wind can blow away buildings at Category 5 hurricane strength to help engineers design safer homes – but even that isn't powerful enough
  10. What are HeLa cells? A cancer biologist explains
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more